![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Deming Paulina Arora Sanjeev
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.20, Iss.10, 2011-10, pp. : 1435-1443
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Telaprevir for the treatment of hepatitis C
By Forestier Nicole Zeuzem Stefan
Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Treatment of Acute Hepatitis C
Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Simeprevir for the treatment of chronic hepatitis C
Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 18, 2013-12 ,pp. :